Impact of cancer types on COVID-19 infection and mortality risk: a protocol for systematic review and meta-analysis.
COVID-19
epidemiology
oncology
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
08 07 2022
08 07 2022
Historique:
entrez:
8
7
2022
pubmed:
9
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
The COVID-19 pandemic has created a huge social and economic burden, and the lifestyles of individuals have significantly changed. In addition, the diagnosis, treatment and management of patients with cancer were greatly affected. Studies have shown that patients with cancer are at a higher risk of COVID-19 infection-related complications, which require aggressive preventive measures. Different types of cancer may have different risks of COVID-19 infection and death, and different preventive care measures are needed for different types of patients with cancer. Here, we designed a protocol for systematic review and meta-analysis to explore the impact of cancer types on COVID-19 infection and mortality risk. A systematic search plan will be performed to filter the eligible studies in the seven databases, namely PubMed, Cochrane search strategy, EMBASE search strategy, SinoMed, China National Knowledge Infrastructure, China Science and Technology Journals Database, and Wanfang database from 2019 to 10 August 2021. Two independent reviewers will choose the eligible studies and extract the data. The risk of bias will be evaluated based on the Newcastle-Ottawa Scale recommended by the Cochrane Collaboration. Finally, a systematic review and meta-analysis will be performed using Review Manager (V.5.3) statistical software. Formal ethical approval is not required, and the findings will be published in a peer-reviewed journal. CRD42021271108.
Identifiants
pubmed: 35803638
pii: bmjopen-2021-058078
doi: 10.1136/bmjopen-2021-058078
pmc: PMC9271838
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e058078Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Clin Pathol. 2021 Mar;74(3):187-189
pubmed: 32561524
Cancers (Basel). 2021 Jan 22;13(3):
pubmed: 33499223
Blood Rev. 2021 May;47:100775
pubmed: 33187811
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Ann Oncol. 2020 Aug;31(8):1065-1074
pubmed: 32442581
Transl Psychiatry. 2020 Jul 31;10(1):263
pubmed: 32737292
Nat Med. 2020 May;26(5):665-671
pubmed: 32405058
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Nat Med. 2020 Aug;26(8):1218-1223
pubmed: 32581323
J Natl Cancer Inst. 2021 Apr 6;113(4):371-380
pubmed: 33136163
Hematol Oncol Stem Cell Ther. 2020 Jul 30;:
pubmed: 32745466
Nat Med. 2021 Jan;27(1):28-33
pubmed: 33442016
Clin Infect Dis. 2021 Jan 27;72(2):340-350
pubmed: 33501974
Oncologist. 2021 Jan;26(1):
pubmed: 32845538
Cancer Discov. 2021 Feb;11(2):233-236
pubmed: 33355178